Oncotelic Therapeutics, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Oncotelic Therapeutics, Inc. (OTLC) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $2.15 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-04-15.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2021-08-20
- Oncotelic Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2020-03-31 was $2.15M, a 700.57% increase year-over-year.
- Oncotelic Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2019-06-30 was $72.42K.
- Oncotelic Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2019-03-31 was $268.26K.
- Oncotelic Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2020 was $2.15M, a 530.39% increase from fiscal 2019.
- Oncotelic Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2019 was $340.67K, a 322.03% increase from fiscal 2018.
- Oncotelic Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2018 was $80.72K.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|
| 2020-12-31 | $2.15M 10-K · filed 2021-04-15 | ||
| 2020-03-31 | $2.15M 10-Q · filed 2021-08-20 | ||
| 2019-12-31 | $340.67K 10-K · filed 2021-04-15 | ||
| 2019-06-30 | $72.42K 10-Q · filed 2020-11-16 | $340.67K derived: sum of 2 quarters · filed 2020-11-16 | |
| 2019-03-31 | $268.26K 10-Q · filed 2020-11-16 | ||
| 2018-12-31 | $80.72K 10-K · filed 2020-05-14 |